AR071261A1 - Variantes de proteasa para uso farmaceutico - Google Patents

Variantes de proteasa para uso farmaceutico

Info

Publication number
AR071261A1
AR071261A1 ARP080105261A ARP080105261A AR071261A1 AR 071261 A1 AR071261 A1 AR 071261A1 AR P080105261 A ARP080105261 A AR P080105261A AR P080105261 A ARP080105261 A AR P080105261A AR 071261 A1 AR071261 A1 AR 071261A1
Authority
AR
Argentina
Prior art keywords
variants
pharmaceutical use
diabetes
treatment
protease variants
Prior art date
Application number
ARP080105261A
Other languages
English (en)
Original Assignee
Novozymes As
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As, Solvay Pharm Gmbh filed Critical Novozymes As
Publication of AR071261A1 publication Critical patent/AR071261A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La solicitud se refiere a variantes de una proteasa derivada de Nocardiopsis sp. (N° ID SEC: 1) y a proteasas estrechamente relacionadas, así como también a su uso farmacéutico. Las variantes muestran un rendimiento en el tratamiento de la insuficiencia exocrina pancreática (PEI). Las variantes se pueden combinar con una lipasa y/o una amilasa. Otros ejemplos de indicaciones médicas son: el tratamiento de trastornos digestivos, pancreatitis, fibrosis quística, diabetes tipo I, y/o diabetes tipo II.
ARP080105261A 2007-12-04 2008-12-03 Variantes de proteasa para uso farmaceutico AR071261A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122243 2007-12-04

Publications (1)

Publication Number Publication Date
AR071261A1 true AR071261A1 (es) 2010-06-09

Family

ID=40310217

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105261A AR071261A1 (es) 2007-12-04 2008-12-03 Variantes de proteasa para uso farmaceutico

Country Status (15)

Country Link
US (1) US8455235B2 (es)
EP (1) EP2220220A1 (es)
JP (1) JP2011505160A (es)
KR (1) KR20100092450A (es)
CN (1) CN101889084A (es)
AR (1) AR071261A1 (es)
AU (1) AU2008333313A1 (es)
BR (1) BRPI0819662A2 (es)
CA (1) CA2707658A1 (es)
IL (1) IL205952A0 (es)
MX (1) MX2010005690A (es)
RU (1) RU2010127329A (es)
TW (1) TW200936158A (es)
WO (1) WO2009071550A1 (es)
ZA (1) ZA201003576B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004279924B2 (en) * 2003-10-10 2010-09-30 Novozymes A/S Protease variants
AU2005254611B2 (en) 2004-06-21 2010-09-23 Novozymes A/S Proteases
WO2008077890A1 (en) * 2006-12-22 2008-07-03 Novozymes A/S Method for producing a yeast extract
FR2972639B1 (fr) * 2011-03-18 2013-11-08 Top Pharm Lab Composition pharmaceutique anti-inflammatoire
US20140147895A1 (en) 2011-07-22 2014-05-29 Novozymes A/S Processes for Pretreating Cellulosic Material and Improving Hydrolysis Thereof
US20130273026A1 (en) * 2012-04-12 2013-10-17 Integrative Enzymatics, Inc. Composition and method for modulating inflammatory molecules with amylase
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK564086A (da) 1986-11-25 1988-06-17 Novo Industri As Enzymatisk detergent-additiv
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
US5614224A (en) * 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics
AU6221496A (en) * 1995-05-31 1996-12-18 Simon Lodewijk Scharpe Composition to improve digestibility and utilisation of nutr ients
NL1001620C2 (en) 1995-06-22 1996-12-24 Instituut Voor Agrobiologisch Improvement in activity of plant growth regulators
FR2747045B1 (fr) * 1996-04-05 1998-06-26 Hooreman Michel Nouveau medicament optimisant la viscosite des mucus et ameliorant le fonctionnement de l'intestin
SK284677B6 (sk) 1999-03-17 2005-09-08 Solvay Pharmaceuticals Gmbh Farmaceutický prípravok na liečbu diabetu a spôsob jeho prípravy
DE60115602T2 (de) 2000-02-08 2006-08-10 Dsm Ip Assets B.V. Verwendung von säurestabilen subtilisinproteasen in tierfutter
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
JP4137526B2 (ja) 2002-01-23 2008-08-20 Ｔｏｔｏ株式会社 ケラチナーゼおよびその製造法
AU2003250830A1 (en) 2002-06-12 2003-12-31 Bayer Healthcare Ag Regulation of human subtilase-like serine protease
WO2004111222A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Proteases
DK1639104T3 (da) 2003-06-19 2010-07-26 Novozymes As Forbedrede proteaser og fremgangsmåder til fremstilling af disse
WO2004111221A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Proteases
US7179630B2 (en) 2003-06-19 2007-02-20 Novozymes A/S Thermostable proteases
WO2004111223A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Proteases
AU2004279924B2 (en) * 2003-10-10 2010-09-30 Novozymes A/S Protease variants
US7985569B2 (en) * 2003-11-19 2011-07-26 Danisco Us Inc. Cellulomonas 69B4 serine protease variants
AU2005247061A1 (en) 2004-05-24 2005-12-08 Novozymes A/S Enzymes for pharmaceutical use
AU2005254611B2 (en) 2004-06-21 2010-09-23 Novozymes A/S Proteases
MX2007015472A (es) 2005-06-24 2008-04-17 Novozymes As Lipasas para uso farmaceutico.
BRPI0611932A2 (pt) 2005-06-24 2011-01-04 Novozymes As amilase, uso da mesma, composição farmacêutica, e, método para o tratamento de uma doença

Also Published As

Publication number Publication date
US20100322915A1 (en) 2010-12-23
MX2010005690A (es) 2010-06-08
IL205952A0 (en) 2010-11-30
TW200936158A (en) 2009-09-01
CA2707658A1 (en) 2009-06-11
ZA201003576B (en) 2011-02-23
US8455235B2 (en) 2013-06-04
CN101889084A (zh) 2010-11-17
AU2008333313A1 (en) 2009-06-11
JP2011505160A (ja) 2011-02-24
KR20100092450A (ko) 2010-08-20
WO2009071550A1 (en) 2009-06-11
BRPI0819662A2 (pt) 2015-06-16
RU2010127329A (ru) 2012-01-10
EP2220220A1 (en) 2010-08-25

Similar Documents

Publication Publication Date Title
NO20080439L (no) Amylaser til farmasoytisk anvendelse
BRPI0510817A (pt) protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de uma doença
AR071261A1 (es) Variantes de proteasa para uso farmaceutico
AR064494A1 (es) Variantes de lipasa para uso farmaceutico
AR053634A1 (es) Lipasas para uso farmaceutico
CY1118984T1 (el) Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων
ES2572160T3 (es) Una nueva preparación farmacéutica para preeclampsia
ATE543907T1 (de) Stresstolerante baumwollpflanzen
NO20080438L (no) Proteaser til farmasoytisk anvendelse
MX363096B (es) Composición farmacéutica para usarse en el tratamiento de la malnutrición en un sujeto que exhibe un trastorno de espectro de autismo (asd).
EA201000399A1 (ru) Композиции и способы использования проостровковых пептидов и их аналогов
AR074311A1 (es) Variantes de subtilisina aislada de bacillus, con actividad proteolitica
AR069168A1 (es) Variantes de alfa -amilasas con propiedades alteradas
CL2008001197A1 (es) Compuestos derivados de amidas sustituidas, moduladoras de la actividad de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo i; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como sindrome metabolico, resistencia a la insulina, dislipidemia, entre otras.
HK1142062A1 (en) Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
WO2011137320A3 (en) Small molecule inhibitors of usp1 deubiquitinating enzyme activity
AR082319A1 (es) Produccion de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
CL2012000658A1 (es) Composicion farmaceutica que comprende microesferas entericamente recubiertas que contienen enzimas digestivas tal como lipasa y microesferas no recubiertas entericamente que contienen enzimas digestivas tal como proteasa; forma de dosis; y su uso tratar el dolor de pancreatitis e insuficiencia pancreatica.
NZ595364A (en) TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION
TH88730A (th) ไลเปสสำหรับการใช้ทางเภสัชกรรม
RS52718B (en) ALBUMIN AND / OR MANITOL FOR THE TREATMENT OF NASAL POLYPOSIS
TH105721A (th) แวเรียนท์ของไลเปสสำหรับการใช้ทางเภสัชกรรม
TH105721B (th) แวเรียนท์ของไลเปสสำหรับการใช้ทางเภสัชกรรม

Legal Events

Date Code Title Description
FB Suspension of granting procedure